ANONYMOUS: 'Detailed results for the IMGT/V-QUEST analsysed sequences', [Online] Retrieved from the Internet: <URL:http://www.imgt.org/IMGT_vquest/vquest > [retrieved on 2012-06-20] (B1)

XIANG YOUGUI ET AL: "The Downstream Transcriptional Enhancer, Ed, positively regulates mouse Ig kappa gene expression and somatic hypermutation." JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 MAY 2008, vol. 180, no. 10, 15 May 2008 (2008-05-15), pages 6725-6732, XP002556636 ISSN: 0022-1767 (B1)

Bjarne Bogen ET AL: "A rearranged lambda 2 light gene chain retards but does not exclude kappa and lambda 1 expression", European Journal of Immunology, vol. 21, 1 January 1991 (1991-01-01), pages 2391-2395, XP55051598, (B1)

DATABASE GENBANK [Online] 28 October 1994 AUCOUTURIER: 'Monoclonal Ig L chain V domain crystallization in myeloma-associated Fanconi's syndrome' Database accession no. M87478 (B1)

DE KRUIF JOHN ET AL: "Human immunoglobulin repertoires against tetanus toxoid contain a large and diverse fraction of high-affinity promiscuous V(H) genes." JOURNAL OF MOLECULAR BIOLOGY 3 APR 2009, vol. 387, no. 3, 3 April 2009 (2009-04-03), pages 548-558, XP002556330 ISSN: 1089-8638 (B1)

DE WILDT R M ET AL: "Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire.", JOURNAL OF MOLECULAR BIOLOGY 22 JAN 1999 LNKD- PUBMED:9887257, vol. 285, no. 3, 22 January 1999 (1999-01-22), pages 895-901, ISSN: 0022-2836 (B1)

EP-A- 1 439 234 (B1)

EP-A2- 0 814 159 (B1)

GONZÁLEZ-FERNÁNDEZ A ET AL: "Analysis of somatic hypermutation in mouse Peyer's patches using immunoglobulin kappa light-chain transgenes.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 1 NOV 1993 LNKD- PUBMED:8234326, vol. 90, no. 21, 1 November 1993 (1993-11-01), pages 9862-9866, ISSN: 0027-8424 (B1)

GOYENECHEA B ET AL: "Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 26 NOV 1996 LNKD- PUBMED:8943046, vol. 93, no. 24, 26 November 1996 (1996-11-26), pages 13979-13984, ISSN: 0027-8424 (B1)

HENGSTSCHLÄGER M ET AL: "A lambda 1 transgene under the control of a heavy chain promoter and enhancer does not undergo somatic hypermutation.", EUROPEAN JOURNAL OF IMMUNOLOGY JUL 1994 LNKD- PUBMED:8026525, vol. 24, no. 7, July 1994 (1994-07), pages 1649-1656, ISSN: 0014-2980 (B1)

HÖMIG-HÖLZEL CORNELIA ET AL: "Constitutive CD40 signaling in B cells selectively activates the noncanonical NF-kappaB pathway and promotes lymphomagenesis." 9 June 2008 (2008-06-09), THE JOURNAL OF EXPERIMENTAL MEDICINE 9 JUN 2008, VOL. 205, NR. 6, PAGE(S) 1317 - 1329 , XP002556639 ISSN: 1540-9538 * page 1318, right-hand column, paragraphs 2,3 * * figure 1 * (B1)

JAKOBOVITS AYA ET AL: "From XenoMouse technology to panitumumab, the first fully human antibody product from transgenic mice." NATURE BIOTECHNOLOGY OCT 2007, vol. 25, no. 10, October 2007 (2007-10), pages 1134-1143, XP002556637 ISSN: 1087-0156 (B1)

JOLLY C J ET AL: "Rapid methods for the analysis of immunoglobulin gene hypermutation: application to transgenic and gene targeted mice.", NUCLEIC ACIDS RESEARCH 15 MAY 1997 LNKD- PUBMED:9115357, vol. 25, no. 10, 15 May 1997 (1997-05-15), pages 1913-1919, ISSN: 0305-1048 (B1)

Jonathan U. Peled ET AL: "The Biochemistry of Somatic Hypermutation", Annual Review of Immunology, vol. 26, no. 1, 1 April 2008 (2008-04-01), pages 481-511, XP55046834, ISSN: 0732-0582, DOI: 10.1146/annurev.immunol.26.021607.090236 (B1)

KLOTZ E L ET AL: "Somatic hypermutation of a lambda 2 transgene under the control of the lambda enhancer or the heavy chain intron enhancer.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 NOV 1996 LNKD- PUBMED:8906822, vol. 157, no. 10, 15 November 1996 (1996-11-15), pages 4458-4463, ISSN: 0022-1767 (B1)

KONG Q ET AL: "A lambda 3' enhancer drives active and untemplated somatic hypermutation of a lambda 1 transgene.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 1 JUL 1998 LNKD- PUBMED:9647236, vol. 161, no. 1, 1 July 1998 (1998-07-01), pages 294-301, ISSN: 0022-1767 (B1)

KWAKS T H J ET AL: "Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells" TRENDS IN BIOTECHNOLOGY, ELSEVIER PUBLICATIONS, CAMBRIDGE, GB, vol. 24, no. 3, 1 March 2006 (2006-03-01), pages 137-142, XP025052307 ISSN: 0167-7799 [retrieved on 2006-03-01] (B1)

LONBERG NILS: "Human antibodies from transgenic animals" NATURE BIOTECHNOLOGY, NATURE PUBLISHING GROUP, NEW YORK, NY, US, vol. 23, no. 9, 1 September 2005 (2005-09-01), pages 1117-1125, XP002442149 ISSN: 1087-0156 (B1)

MOHAMMED ATTAELMANNAN ET AL: "Understanding and identifying monoclonal gammopathies", CLINICAL CHEMISTRY, vol. 46, 1 January 2000 (2000-01-01), pages 1230-1238, XP55070489, (B1)

NEUBERGER M S ET AL: "ISOTYPE EXCLUSION AND TRANSGENE DOWN-REGULATION IN IMMUNOGLOBULIN-LAMBDA TRANSGENIC MICE", NATURE: INTERNATIONAL WEEKLY JOURNAL OF SCIENCE, NATURE PUBLISHING GROUP, UNITED KINGDOM, vol. 338, 23 March 1989 (1989-03-23), pages 350-352, XP001093655, ISSN: 0028-0836, DOI: 10.1038/338350A0 (B1)

ODEGARD VALERIE H ET AL: "Targeting of somatic hypermutation." NATURE REVIEWS. IMMUNOLOGY AUG 2006, vol. 6, no. 8, August 2006 (2006-08), pages 573-583, XP002556635 ISSN: 1474-1733 (B1)

PELANDA R ET AL: "A prematurely expressed Ig(kappa) transgene, but not V(kappa)J(kappa) gene segment targeted into the Ig(kappa) locus, can rescue B cell development in lambda5-deficient mice." IMMUNITY SEP 1996, vol. 5, no. 3, September 1996 (1996-09), pages 229-239, XP002556633 ISSN: 1074-7613 (B1)

PETER-CHRISTIAN KLÖHN ET AL: "IBC's 23nd Annual Antibody Engineering, 10th Annual Antibody Therapeutics International Conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA", MABS, vol. 5, no. 2, 1 March 2013 (2013-03-01), pages 178-201, XP55070468, ISSN: 1942-0862, DOI: 10.4161/mabs.23655 (B1)

PRESTA ET AL: "Engineering of therapeutic antibodies to minimize immunogenicity and optimize function" ADVANCED DRUG DELIVERY REVIEWS, ELSEVIER BV, AMSTERDAM, NL, vol. 58, no. 5-6, 7 August 2006 (2006-08-07), pages 640-656, XP024892146 ISSN: 0169-409X [retrieved on 2006-08-07] (B1)

SHARPE M J ET AL: "Somatic hypermutation of immunglobulin kappa may depend on sequences 3' of c-kappa and occurs on passenger transgenes", EMBO JOURNAL, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 10, no. 8, 1 August 1991 (1991-08-01) , pages 2139-2145, XP002130745, ISSN: 0261-4189 (B1)

SIRAC CHRISTOPHE ET AL: "Role of the monoclonal kappa chain V domain and reversibility of renal damage in a transgenic model of acquired Fanconi syndrome", BLOOD, vol. 108, no. 2, July 2006 (2006-07), pages 536-543, ISSN: 0006-4971 (B1)

SMITH-GILL S J ET AL: "Contributions of immunoglobulin heavy and light chains to antibody specificity for lysozyme and two haptens." JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 DEC 1987, vol. 139, no. 12, 15 December 1987 (1987-12-15), pages 4135-4144, XP002556638 ISSN: 0022-1767 (B1)

US-A1- 2012 192 300 (B1)

WEINER LOUIS M: "Fully human therapeutic monoclonal antibodies" JOURNAL OF IMMUNOTHERAPY, LIPPINCOTT WILLIAMS & WILKINS, HAGERSTOWN, MD, US, vol. 29, no. 1, 1 January 2006 (2006-01-01), pages 1-9, XP009118693 ISSN: 1524-9557 (B1)

WINTER D B ET AL: "Insertion of 2 kb of bacteriophage DNA between an immunoglobulin promoter and leader exon stops somatic hypermutation in a kappa transgene." MOLECULAR IMMUNOLOGY APR 1997, vol. 34, no. 5, April 1997 (1997-04), pages 359-366, XP002556634 ISSN: 0161-5890 (B1)

WO-A1-02/066630 (B1)

WO-A2-98/50431 (B1)

AUCOUTURIER PIERRE ET AL: "Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome", JOURNAL OF IMMUNOLOGY, vol. 150, no. 8 PART 1, 1993, pages 3561-3568, ISSN: 0022-1767 (B1)